Abstract
Cystic fibrosis transmembrane conductance regulator (CFTR) channel gating is predominantly regulated by protein kinase A (PKA)-dependent phosphorylation. In addition to regulating CFTR channel activity, PKA phosphorylation is also involved in enhancing CFTR trafficking and mediating conformational changes at the interdomain interfaces of the protein. The major cystic fibrosis (CF)-causing mutation is the deletion of phenylalanine at position 508 (F508del); it causes many defects that affect CFTR trafficking, stability, and gating at the cell surface. Due to the multiple roles of PKA phosphorylation, there is growing interest in targeting PKA-dependent signaling for rescuing the trafficking and functional defects of F508del-CFTR. This review will discuss the effects of PKA phosphorylation on wild-type CFTR, the consequences of CF mutations on PKA phosphorylation, and the development of therapies that target PKA-mediated signaling.
Similar content being viewed by others
References
Billet A et al (2016) Potential sites of CFTR activation by tyrosine kinases. Channels (Austin) 10(3):247–251
Billet A et al (2015) Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation. Faseb J 29(9):3945–3953
Billet A, Hanrahan JW (2013) The secret life of CFTR as a calcium-activated chloride channel. J Physiol 591(21):5273–5278
Rabeh WM et al (2012) Correction of both NBD1 energetics and domain interface is required to restore DeltaF508 CFTR folding and function. Cell 148(1–2):150–163
Okiyoneda T et al (2013) Mechanism-based corrector combination restores DeltaF508-CFTR folding and function. Nat Chem Biol 9(7):444–454
McDonald RA et al (1995) Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity. Proc Natl Acad Sci U S A 92(16):7560–7564
Matthews RP, McKnight GS (1996) Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter. J Biol Chem 271(50):31869–31877
Pasyk S et al (2015) The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Proteomics 15(2–3):447–461
Gadsby DC, Nairn AC (1994) Regulation of CFTR channel gating. Trends Biochem Sci 19(11):513–518
Csanady L et al (2005) Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA. J Gen Physiol 125(2):171–186
Cheng SH et al (1991) Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66(5):1027–1036
Chang XB et al (1993) Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem 268(15):11304–11311
Seibert FS et al (1999) Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum. Biochim Biophys Acta 1461(2):275–283
Wilkinson DJ et al (1997) CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol 273(1 Pt 1):L127–L133
Hegedus T et al (2009) Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A. Biochim Biophys Acta 1788(6):1341–1349
Neville DC et al (1997) Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci 6(11):2436–2445
McClure M et al (2012) Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications. Protein Eng Des Sel 25(1):7–14
Liang X et al (2012) Phosphorylation-dependent 14-3-3 protein interactions regulate CFTR biogenesis. Mol Biol Cell 23(6):996–1009
Rennolds J et al (2008) Cystic fibrosis transmembrane conductance regulator trafficking is mediated by the COPI coat in epithelial cells. J Biol Chem 283(2):833–839
Stevers LM et al (2016) Characterization and small-molecule stabilization of the multisite tandem binding between 14-3-3 and the R domain of CFTR. Proc Natl Acad Sci U S A 113(9):E1152–E1161
Cantiello HF (1996) Role of the actin cytoskeleton in the regulation of the cystic fibrosis transmembrane conductance regulator. Exp Physiol 81(3):505–514
Louvet-Vallee S (2000) ERM proteins: from cellular architecture to cell signaling. Biol Cell 92(5):305–316
Naren AP et al (2003) A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci U S A 100(1):342–346
Li C et al (2004) Molecular assembly of cystic fibrosis transmembrane conductance regulator in plasma membrane. J Biol Chem 279(23):24673–24684
Moyer BD et al (2000) The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J Biol Chem 275(35):27069–27074
Short DB et al (1998) An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 273(31):19797–19801
Sun F et al (2000) E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J Biol Chem 275(38):29539–29546
Monterisi S et al (2012) CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity. J Cell Sci 125(Pt 5):1106–1117
Alshafie W et al (2014) VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCepsilon-dependent manner. Am J Physiol Cell Physiol 307(1):C107–C119
Lobo MJ et al (2016) EPAC1 activation by cAMP stabilizes CFTR at the membrane by promoting its interaction with NHERF1. J Cell Sci 129(13):2599–2612
Holleran JP et al (2013) Regulated recycling of mutant CFTR is partially restored by pharmacological treatment. J Cell Sci 126(Pt 12):2692–2703
Bear CE et al (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68(4):809–818
Aleksandrov AA, Cui L, Riordan JR (2009) Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator. J Physiol 587(Pt 12):2875–2886
Zhou Z et al (2006) The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics. J Gen Physiol 128(4):413–422
Vergani P et al (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433(7028):876–880
Aleksandrov AA, Aleksandrov LA, Riordan JR (2007) CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers Arch 453(5):693–702
Gadsby DC, Vergani P, Csanady L (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440(7083):477–483
Cheung JC et al (2008) Molecular basis for the ATPase activity of CFTR. Arch Biochem Biophys 476(1):95–100
Scott-Ward TS et al (2007) Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR. Proc Natl Acad Sci U S A 104(41):16365–16370
Bompadre SG et al (2007) G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects. J Gen Physiol 129(4):285–298
Ramjeesingh M et al (2008) The intact CFTR protein mediates ATPase rather than adenylate kinase activity. Biochem J 412(2):315–321
Stratford FL et al (2007) The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer. Biochem J 401(2):581–586
Kogan I et al (2002) Studies of the molecular basis for cystic fibrosis using purified reconstituted CFTR protein. Methods Mol Med 70:143–157
Kogan I et al (2001) Perturbation of the pore of the cystic fibrosis transmembrane conductance regulator (CFTR) inhibits its atpase activity. J Biol Chem 276(15):11575–11581
Kidd JF et al (2004) A heteromeric complex of the two nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) mediates ATPase activity. J Biol Chem 279(40):41664–41669
Dawson RJ, Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443(7108):180–185
Locher KP (2009) Review. Structure and mechanism of ATP-binding cassette transporters. Philos Trans R Soc Lond B Biol Sci 364(1514):239–245
Serohijos AW et al (2008) Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A 105(9):3256–3261
Mornon JP, Lehn P, Callebaut I (2008) Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces. Cell Mol Life Sci 65(16):2594–2612
Winter MC, Welsh MJ (1997) Stimulation of CFTR activity by its phosphorylated R domain. Nature 389(6648):294–296
Hwang TC, Sheppard DN (2009) Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation. J Physiol 587(Pt 10):2151–2161
Mihalyi C, Torocsik B, Csanady L (2016) Obligate coupling of CFTR pore opening to tight nucleotide-binding domain dimerization. Elife 5:e18164
Li C, Ramjeesingh M, Bear CE (1996) Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel. J Biol Chem 271(20):11623–11626
Szellas T, Nagel G (2003) Apparent affinity of CFTR for ATP is increased by continuous kinase activity. FEBS Lett 535(1–3):141–146
Li C et al (1996) ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 271(45):28463–28468
Zwick M et al (2016) How phosphorylation and ATPase activity regulate anion flux though the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 291(28):14483–14498
Wang W et al (2010) ATP-independent CFTR channel gating and allosteric modulation by phosphorylation. Proc Natl Acad Sci U S A 107(8):3888–3893
Ostedgaard LS, Baldursson O, Welsh MJ (2001) Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by its R domain. J Biol Chem 276(11):7689–7692
Baker JM et al (2007) CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol 14(8):738–745
Kanelis V et al (2010) NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J 29(1):263–277
Hudson RP et al (2012) Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 287(34):28480–28494
Dawson JE, Farber PJ, Forman-Kay JD (2013) Allosteric coupling between the intracellular coupling helix 4 and regulatory sites of the first nucleotide-binding domain of CFTR. PLoS One 8(9):e74347
Grimard V et al (2004) Phosphorylation-induced conformational changes of cystic fibrosis transmembrane conductance regulator monitored by attenuated total reflection-Fourier transform IR spectroscopy and fluorescence spectroscopy. J Biol Chem 279(7):5528–5536
Chappe V et al (2005) Phosphorylation of CFTR by PKA promotes binding of the regulatory domain. EMBO J 24(15):2730–2740
Lewis HA et al (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J 23(2):282–293
Mense M et al (2006) In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J 25(20):4728–4739
He L et al (2008) Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J Biol Chem 283(39):26383–26390
Fu J, Kirk KL (2001) Cysteine substitutions reveal dual functions of the amino-terminal tail in cystic fibrosis transmembrane conductance regulator channel gating. J Biol Chem 276(38):35660–35668
Naren AP et al (1999) CFTR chloride channel regulation by an interdomain interaction. Science 286(5439):544–548
Bertrand CA et al (2009) SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 133(4):421–438
Ehrhardt A et al (2016) Channel gating regulation by the cystic fibrosis transmembrane conductance regulator (CFTR) first cytosolic loop. J Biol Chem 291(4):1854–1865
Wang W, Roessler BC, Kirk KL (2014) An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening. J Biol Chem 289(44):30364–30378
Gregory RJ et al (1991) Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 11(8):3886–3893
Eckford PD et al (2012) Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner. J Biol Chem 287(44):36639–36649
Pasyk S et al (2009) Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease. Biochem J 418(1):185–190
Ren XQ et al (2004) Function of the ABC signature sequences in the human multidrug resistance protein 1. Mol Pharmacol 65(6):1536–1542
Riordan JR (2005) Assembly of functional CFTR chloride channels. Annu Rev Physiol 67:701–718
Younger JM et al (2004) A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J Cell Biol 167(6):1075–1085
Younger JM et al (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126(3):571–582
Farinha CM, Amaral MD (2005) Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol Cell Biol 25(12):5242–5252
Okiyoneda T et al (2004) Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol Biol Cell 15(2):563–574
Okiyoneda T et al (2010) Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329(5993):805–810
Gentzsch M et al (2004) Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 15(6):2684–2696
Loo TW, Bartlett MC, Clarke DM (2008) Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 283(42):28190–28197
He L et al (2013) Correctors of DeltaF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein. FASEB J 27(2):536–545
Aleksandrov AA et al (2010) Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. J Mol Biol 401(2):194–210
Wang F et al (2000) Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels. J Physiol 524(Pt 3):637–648
Drumm ML et al (1991) Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science 254(5039):1797–1799
Hegedus T et al (2006) F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochim Biophys Acta 1758(5):565–572
Kim Chiaw P et al (2009) Functional rescue of DeltaF508-CFTR by peptides designed to mimic sorting motifs. Chem Biol 16(5):520–530
Chang XB et al (1999) Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell 4(1):137–142
Favia M et al (2010) Na +/H + exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells. Mol Biol Cell 21(1):73–86
Denning GM et al (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358(6389):761–764
Farinha CM et al (2013) Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction. Chem Biol 20(7):943–955
Pedemonte N et al (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115(9):2564–2571
Van Goor F et al (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 108(46):18843–18848
Abbattiscianni AC et al (2016) Correctors of mutant CFTR enhance subcortical cAMP-PKA signaling through modulating ezrin phosphorylation and cytoskeleton organization. J Cell Sci 129(6):1128–1140
Van Goor F et al (2009) Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A 106(44):18825–18830
Jih KY, Hwang TC (2013) Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle. Proc Natl Acad Sci U S A 110(11):4404–4409
Loureiro CA et al (2015) A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint. Sci Signal 8(377):ra48
Turner MJ et al (2016) The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia. Am J Physiol Lung Cell Mol Physiol 310(1):L59–L70
Li C, Naren AP (2011) Analysis of CFTR interactome in the macromolecular complexes. Methods Mol Biol 741:255–270
Li C, Naren AP (2010) CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. Integr Biol (Camb) 2(4):161–177
Moon C et al (2015) Compartmentalized accumulation of cAMP near complexes of multidrug resistance protein 4 (MRP4) and cystic fibrosis transmembrane conductance regulator (CFTR) contributes to drug-induced diarrhea. J Biol Chem 290(18):11246–11257
Li C et al (2007) Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 131(5):940–951
Arora K, Naren AP (2016) Pharmacological correction of cystic fibrosis: molecular mechanisms at the plasma membrane to augment mutant CFTR function. Curr Drug Targets 17(11):1275–1281
Acknowledgments
S. Chin was supported by a NSERC scholarship (PGS-D) and the research activities in the Bear Lab supported in part by the Canadian Institutes of Health Research and Cystic Fibrosis Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chin, S., Hung, M. & Bear, C.E. Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants. Cell. Mol. Life Sci. 74, 57–66 (2017). https://doi.org/10.1007/s00018-016-2388-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-016-2388-6